Status:

COMPLETED

Exploration of Investigating ICU Mobilisation With Vasoactive Drugs

Lead Sponsor:

Imperial College London

Conditions:

Critical Illness

Eligibility:

All Genders

18+ years

Brief Summary

There is a need to know more about the safety of mobilizing intensive care unit (ICU) patients who are receiving vasoactive drugs that support the heart and blood pressure. But before this research ca...

Detailed Description

The current evidence is insufficient to accurately guide clinicians to know when it is safe to start mobilizing intensive care unit (ICU) patients receiving vasoactive drugs. Before a randomized contr...

Eligibility Criteria

Inclusion

  • Patient participants:
  • Patients admitted to the ICU who are receiving vasoactive drugs.
  • Age greater than or equal to 18 years old.
  • Expected to remain admitted to the ICU for at least 24 hours post-enrolment.

Exclusion

  • Any patient who is expected to die imminently, as per clinical opinion.
  • Any patient where mobilization is contraindicated by the nature of their existing injuries.
  • Where it is clear from the medical records that participants are prisoners or offenders on probation.
  • Patients with neuromuscular disease or acute brain injury or spinal cord injury.
  • If the patient and/or their consultee is unable to speak English.
  • Clinicians participating in a survey on hypothetical randomization of patient participants:
  • Inclusion criteria:
  • Clinicians who work in the intensive care unit where a patient participant has been admitted.
  • Exclusion criteria:
  • None.
  • Clinician participants in the survey on the feasibility of the ICU physical rehabilitation adverse event tool:
  • Inclusion criteria:
  • An ICU clinician at the research site.
  • Has used the ICU physical rehabilitation adverse event tool as part of this research study.
  • Exclusion criteria:
  • None.

Key Trial Info

Start Date :

December 14 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 9 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03869541

Start Date

December 14 2018

End Date

August 9 2019

Last Update

November 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Imperial College Healthcare NHS Trust

London, United Kingdom